EFFICACY AND SAFETY OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS: AN ANALYSIS OF THE ITALIAN PATIENTS FROM A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDY

被引：1
|
作者：
Andreone, P. [1 ]
Mazzella, G. [1 ]
Invernizzi, P. [2 ]
Floreani, A. [3 ]
Picaro, L. A. [4 ]
Adorini, L. [5 ]
机构：
[1] Univ Bologna, Bologna, Italy
[2] Humanitas Clin & Res Ctr, Rozzano, MI, Italy
[3] Univ Padua, Padua, Italy
[4] Intercept Pharmaceut LTD Europe, London, England
[5] Intercept Pharmaceut Inc, S Diego, CA USA
来源：
DIGESTIVE AND LIVER DISEASE | 2016年 / 48卷
关键词：
D O I：
10.1016/S1590-8658(16)30035-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC.03.4
引用
收藏
页码：E81 / E81
页数：1
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: AN ANALYSIS OF THE ITALIAN PATIENTS FROM A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    Floreani, A.
    Andreone, P.
    Invernizzi, P.
    Mazzella, G.
    Owens-Grillo, J.
    Malecha, E. Smoot
    Macconell, L.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 : E74 - E74
  • [2] Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study
    Hirschfield, Gideon M.
    Shiffman, Mitchell L.
    Gulamhusein, Aliya
    Kowdley, Kris, V
    Vierling, John M.
    Levy, Cynthia
    Kremer, Andreas E.
    Zigmond, Ehud
    Andreone, Pietro
    Gordon, Stuart C.
    Bowlus, Christopher L.
    Lawitz, Eric J.
    Aspinall, Richard J.
    Pratt, Daniel S.
    Raikhelson, Karina
    Gonzalez-Huezo, Maria S.
    Heneghan, Michael A.
    Jeong, Sook-Hyang
    Ladron de Guevara, Alma L.
    Mayo, Marlyn J.
    Dalekos, George N.
    Drenth, Joost P. H.
    Janczewska, Ewa
    Leggett, Barbara A.
    Nevens, Frederik
    Vargas, Victor
    Zuckerman, Eli
    Corpechot, Christophe
    Fassio, Eduardo
    Hinrichsen, Holger
    Invernizzi, Pietro
    Trivedi, Palak J.
    Forman, Lisa
    Jones, David E. J.
    Ryder, Stephen D.
    Swain, Mark G.
    Steinberg, Alexandra
    Boudes, Pol F.
    Choi, Yun-Jung
    McWherter, Charles A.
    HEPATOLOGY, 2023, 78 (02) : 397 - 415
  • [3] EFFICACY AND SAFETY OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND COMPENSATED CIRRHOSIS IN THE PHASE 3 PLACEBO-CONTROLLED RESPONSE TRIAL
    Villamil, Alejandra
    Younes, Ziad
    Bowlus, Christopher
    Vierling, John
    Vasura, Adam
    Galli, Andrea
    Rabinovitz, Mordechai
    Nevens, Frederik
    Carroll, Susheela
    Yang, Ke
    Crittenden, Daria
    McWherter, Charles
    Lawitz, Eric
    HEPATOLOGY, 2024, 80 : S517 - S518
  • [4] EFFICACY AND SAFETY OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS IN THE RESPONSE TRIAL: A PHASE 3 INTERNATIONAL, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    Hirschfield, Gideon M.
    Bowlus, Christopher L.
    Mayo, Marlyn J.
    Kremer, Andreas E.
    Vierling, John M.
    Kowdley, Kris V.
    Levy, Cynthia
    Carroll, Susheela
    Yang, Ke
    Choi, Yun-Jung
    Crittenden, Daria B.
    McWherter, Charles A.
    HEPATOLOGY, 2024, 79 (02) : E34 - E35
  • [5] A Randomized, Placebo-Controlled Clinical Trial of Efficacy and Safety: Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis
    Silveira, Marina G.
    Gossard, Andrea A.
    Stahler, Alisha C.
    Jorgensen, Roberta A.
    Petz, Janice L.
    Ali, Ahmad H.
    Lindor, Keith D.
    AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (02) : E167 - E176
  • [6] EFFICACY OF OBETICHOLIC ACID TREATMENT IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS WITH CIRRHOSIS
    Vierling, J. M.
    Hirschfield, G.
    Jones, D. E.
    Groszmann, R.
    Kowdley, K. V.
    Pencek, R.
    Marmon, T.
    MacConell, L.
    GUT, 2017, 66 : A100 - A101
  • [7] A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
    Kowdley, Kris, V
    Vuppalanchi, Raj
    Levy, Cynthia
    Floreani, Annarosa
    Andreone, Pietro
    LaRusso, Nicholas F.
    Shrestha, Roshan
    Trotter, James
    Goldberg, David
    Rushbrook, Simon
    Hirschfield, Gideon M.
    Schiano, Thomas
    Jin, Yuying
    Pencek, Richard
    MacConell, Leigh
    Shapiro, David
    Bowlus, Christopher L.
    JOURNAL OF HEPATOLOGY, 2020, 73 (01) : 94 - 101
  • [8] Efficacy of Obeticholic Acid Treatment in Patients with Primary Biliary Cholangitis with Cirrhosis
    Vierling, John M.
    Hirschfield, Gideon M.
    Jones, David
    Groszmann, Roberto J.
    Kowdley, Kris V.
    Pencek, Richard
    Marmon, Tonya
    MacConell, Leigh
    HEPATOLOGY, 2016, 64 : 187A - 187A
  • [9] A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
    Nevens, F.
    Andreone, P.
    Mazzella, G.
    Strasser, S. I.
    Bowlus, C.
    Invernizzi, P.
    Drenth, J. P. H.
    Pockros, P. J.
    Regula, J.
    Beuers, U.
    Trauner, M.
    Jones, D. E.
    Floreani, A.
    Hohenester, S.
    Luketic, V.
    Shiffman, M.
    van Erpecum, K. J.
    Vargas, V.
    Vincent, C.
    Hirschfield, G. M.
    Shah, H.
    Hansen, B.
    Lindor, K. D.
    Marschall, H-U
    Kowdley, K. V.
    Hooshmand-Rad, R.
    Marmon, T.
    Sheeron, S.
    Pencek, R.
    MacConell, L.
    Pruzanski, M.
    Shapiro, D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (07): : 631 - 643
  • [10] LONG-TERM SAFETY OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS
    Peters, Y.
    Hooshmand-rad, R.
    Pencek, R.
    Owens-grillo, J.
    Marmon, T.
    Macconell, L.
    Picaro, L. A.
    Adorini, L.
    Shapiro, D.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E117 - E118
12345